null

SMILES: OC[C@@H]1[C@@H](O)[C@H](O)CNC11CC1

InChI Key: InChIKey=UVWFVBWKBBONDJ-FSDSQADBSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 285820   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Lysosomal acid glucosylceramidase (Homo sapiens (Human))	BDBM285820 ((6R,7R,8R)-8-(hydroxymethyl)-4-azaspiro[2.5]octane...) Show SMILES OC[C@@H]1[C@@H](O)[C@H](O)CNC11CC1 |r| Show InChI InChI=1S/C8H15NO3/c10-4-5-7(12)6(11)3-9-8(5)1-2-8/h5-7,9-12H,1-4H2/t5-,6-,7-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	7	n/a	n/a	n/a	n/a	n/a	n/a	7.0	n/a
Alectos Therapeutics Inc. US Patent					Assay Description Various concentrations of test compounds were prepared in DMSO and then diluted into buffer consisting of 50 mM sodium phosphate 0.25% w/v sodium tau...				US Patent US10081601 (2018) BindingDB Entry DOI: 10.7270/Q2S184JZ
					More data for this Ligand-Target Pair
Lysosomal acid glucosylceramidase (Homo sapiens (Human))	BDBM285820 ((6R,7R,8R)-8-(hydroxymethyl)-4-azaspiro[2.5]octane...) Show SMILES OC[C@@H]1[C@@H](O)[C@H](O)CNC11CC1 |r| Show InChI InChI=1S/C8H15NO3/c10-4-5-7(12)6(11)3-9-8(5)1-2-8/h5-7,9-12H,1-4H2/t5-,6-,7-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	7	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Alectos Therapeutics Inc. US Patent					Assay Description Various concentrations of test compounds were prepared in DMSO and then diluted into buffer consisting of 50 mM sodium phosphate 0.25% w/v sodium tau...				US Patent US9796680 (2017) BindingDB Entry DOI: 10.7270/Q2SN0C36
					More data for this Ligand-Target Pair
Lysosomal acid glucosylceramidase (Homo sapiens (Human))	BDBM285820 ((6R,7R,8R)-8-(hydroxymethyl)-4-azaspiro[2.5]octane...) Show SMILES OC[C@@H]1[C@@H](O)[C@H](O)CNC11CC1 |r| Show InChI InChI=1S/C8H15NO3/c10-4-5-7(12)6(11)3-9-8(5)1-2-8/h5-7,9-12H,1-4H2/t5-,6-,7-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Alectos Therapeutics Inc. US Patent					Assay Description Various concentrations of test compounds were prepared in DMSO and then diluted into buffer consisting of 50 mM sodium phosphate 0.25% w/v sodium tau...				US Patent US9796680 (2017) BindingDB Entry DOI: 10.7270/Q2SN0C36
					More data for this Ligand-Target Pair
Lysosomal acid glucosylceramidase (Homo sapiens (Human))	BDBM285820 ((6R,7R,8R)-8-(hydroxymethyl)-4-azaspiro[2.5]octane...) Show SMILES OC[C@@H]1[C@@H](O)[C@H](O)CNC11CC1 |r| Show InChI InChI=1S/C8H15NO3/c10-4-5-7(12)6(11)3-9-8(5)1-2-8/h5-7,9-12H,1-4H2/t5-,6-,7-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	7.0	n/a
Alectos Therapeutics Inc. US Patent					Assay Description Various concentrations of test compounds were prepared in DMSO and then diluted into buffer consisting of 50 mM sodium phosphate 0.25% w/v sodium tau...				US Patent US10081601 (2018) BindingDB Entry DOI: 10.7270/Q2S184JZ
					More data for this Ligand-Target Pair